My understanding was about 3 months ago GSK was looking to China to be a manufacturer of Relenza on their behalf in case of pandemic.I saw this on the frum and probably posted by aboboCant find it quickly, maybe someone can help
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%